Trading Window Closed Ahead of Q2 FY26-27 Results

Compliance View source PDF Explain this filing

SUVEN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-4.3%Reaction day

₹335.90

prior close

₹321.80

announcement price

In-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.6%-2.7% vs market

Healthcare Research Analytics & Technology peers, median of 5sector-2.0%-2.3% vs sector

On the reaction day the stock moved 2.7 pts less than Nifty Microcap 250 and 2.3 pts less than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.1

10m

+0.0

15m

+0.0

30m

-0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-4.3-1.6-2.7-2.0-2.3

Next day

-3.5-0.6-3.0-1.5-2.0

-5.0-0.8-4.2-3.5-1.5

-8.5-2.1-6.4-4.0-4.5

-9.1-2.1-7.0-5.9-3.2

-7.5-0.8-6.7-4.7-2.8

-14.5-3.8-10.7-7.8-6.6

15d

-17.4-6.9-10.5-13.5-3.9

-20.0pendingpending-15.1-4.9

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Suven Life Sciences has closed its trading window from October 1, 2026, until 48 hours after it announces unaudited financial results for Q2 and half year ended September 30, 2026. During this period, designated persons and their immediate relatives cannot trade in the company's shares. This is a routine compliance measure under SEBI insider trading rules. The board meeting date for approving the Q2 results will be communicated later.

Likely market impact

No impact on retail investors. Designated insiders barred from trading until 48 hours after Q2 results are declared. Routine compliance measure.